Search

everythinglearnresearchcommunity

for

Search:↓

Common hair loss disorders may not need stem cell therapy, but could benefit from other treatments like hair cycle control and immune restoration therapy.

Targeting the PGD2-DP2 pathway may help treat hair loss.

Hair transplantation successfully treated hair loss in a patient with Trichorhinophalangeal syndrome.

Conflicting findings in androgenic alopecia are likely due to biopsy location, hair diameter diversity, and hair follicle miniaturization.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Topical minoxidil effectively stimulates hair growth in men with hair loss.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The document concludes that hair follicle regeneration involves various factors like stem cells, noncoding dsRNA, lymphatic vessels, growth factors, minoxidil, exosomes, and induced pluripotent stem cells.

The 3D-SeboSkin model effectively simulates Hidradenitis suppurativa and is useful for future research.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Valproic acid increases hair count in men with hair loss.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

Severe baldness on the top of the head is linked to a higher chance of heart disease, especially in men under 60.

Hair thickness matters more than density for baldness in Japanese men over 25.

UV-B light increases inflammation-related substances in acne-related skin cells.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Women's hair grows faster and thicker than men's, but hair growth slows for both genders with pattern hair loss.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

The article suggests that the view of male baldness as a medical issue is influenced by commercial bias and calls for more unbiased research.

Male pattern baldness might have evolved to help protect against prostate cancer by increasing UV radiation on the scalp.